产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 | |||
| 1g | 99% | 现货 | |||
| 5g | 99% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 | |||
| 1g | 99% | 现货 | |||
| 5g | 99% | 现货 |
CAS No. |
1346242-81-6 |
|---|---|
中文名称 |
N1-(3,5-二甲氧基苯基)-N2-异丙基-N1-(3-(1-甲基-1H-吡唑-4-基)喹喔啉-6-基)乙烷-1,2-二胺 |
英文名称 |
N1-(3,5-Dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine |
别名 |
AS-35040 | Erdafitinib(JNJ-42756493) | NCGC00475735-01 | BCP20346 | DTXSID001027936 | ERDAFITINIB [WHO-DD] | JNJ 42756493 | N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine | Balversa (TN) | F0001-1665 |
标准英文名 |
N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine |
MDL No. |
MFCD28502040 |
分子式 |
C25H30N6O2 |
分子量 |
446.55 |
精确分子量 |
446.24 |
SMILES |
CN1N=CC(C2=NC3=CC(N(C4=CC(OC)=CC(OC)=C4)CCNC(C)C)=CC=C3N=C2)=C1 |
标准SMILES |
CN1C=C(C=N1)C1C=NC2=CC=C(C=C2N=1)N(CCNC(C)C)C1C=C(C=C(C=1)OC)OC |
性状 |
Pale-yellow to Yellow-brown Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
OLAHOMJCDNXHFI-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ),Specific target organ toxicity, single exposure;Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|